|
Bextra®
class action Pennsylvania.
If
you are currently taking Bextra check with your doctor.
Withdrawal
On
April 7, 2005 the FDA announced that it has asked Pfizer, Inc.
to withdraw Bextra from the
market "because the overall risk versus benefit profile for
the drug is unfavorable."
Bextra® is a non-steroidal anti-inflammatory drug
(NSAIDs), known as a COX-2 selective agent. It is
prescribed for inflammation and pain from arthritis or menstrual
cramping. Other drugs in this class include Celebrex® and
Vioxx®. Bextra® and Celebrex® are both marketed by
Pharmacia Corporation and Pfizer. Vioxx® is manufactured by Merck. Doctors switched patients
from Vioxx® to Bextra® when Merck voluntarily removed it from the
market due to studies showing an increased risk for heart attack
and stroke.
bextra
site map
For attorney information check
these sites out:
For
further information from the government's Food and Drug
Administration try these sites:
Autism
Education Materials for early intervention!
|
